NCT03048695View on ClinicalTrials.gov

Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia

NACompletedINTERVENTIONAL
Enrollment

83

Participants

Timeline

Start Date

May 18, 2017

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2020

Conditions
SchizophreniaNeurocognitive Disorders
Interventions
BEHAVIORAL

GMT

Metacognitive strategy training where the primary objective is to stop ongoing behavior to define goal hierarchies and monitor performance

Trial Locations (1)

2840

Sykehuset Innlandet Reinsvoll, Reinsvoll

All Listed Sponsors
collaborator

University of Oslo

OTHER

lead

Sykehuset Innlandet HF

OTHER

NCT03048695 - Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia | Biotech Hunter | Biotech Hunter